Alembic Limited (ALEMBICLTD.NS)
INR 97.91
(2.59%)
INR 97.91
(2.59%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 2.68 Billion INR | 40.9% |
| 2022 | 1.9 Billion INR | -14.14% |
| 2021 | 2.22 Billion INR | -35.23% |
| 2020 | 3.42 Billion INR | 4.17% |
| 2019 | 3.29 Billion INR | 54.44% |
| 2018 | 2.13 Billion INR | 30.76% |
| 2017 | 1.62 Billion INR | 12.1% |
| 2016 | 1.45 Billion INR | -37.94% |
| 2015 | 2.34 Billion INR | 870.17% |
| 2014 | 241.48 Million INR | -18.21% |
| 2013 | 295.27 Million INR | 156.9% |
| 2012 | 114.93 Million INR | -91.17% |
| 2011 | 1.3 Billion INR | 1108.63% |
| 2010 | -129.01 Million INR | -132.63% |
| 2009 | 395.37 Million INR | 265.41% |
| 2008 | 108.2 Million INR | -90.36% |
| 2007 | 1.12 Billion INR | 58.73% |
| 2006 | 706.81 Million INR | -9.98% |
| 2005 | 785.21 Million INR | 51.54% |
| 2004 | 518.16 Million INR | 65.77% |
| 2003 | 312.58 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 558.2 Million INR | -22.63% |
| 2023 Q1 | 443.8 Million INR | -8.02% |
| 2023 FY | 2.68 Billion INR | 40.9% |
| 2023 Q2 | 906.8 Million INR | 104.33% |
| 2023 Q3 | 614.2 Million INR | -32.27% |
| 2023 Q4 | 721.49 Million INR | 17.47% |
| 2022 Q4 | 482.49 Million INR | 5.76% |
| 2022 Q1 | -185.5 Million INR | -2140.7% |
| 2022 Q2 | 1.15 Billion INR | 721.73% |
| 2022 Q3 | 456.2 Million INR | -60.44% |
| 2022 FY | 1.9 Billion INR | -14.14% |
| 2021 FY | 2.22 Billion INR | -35.23% |
| 2021 Q4 | 9.09 Million INR | -98.25% |
| 2021 Q3 | 519.2 Million INR | -56.79% |
| 2021 Q2 | 1.2 Billion INR | 144.92% |
| 2021 Q1 | 490.6 Million INR | -31.81% |
| 2020 Q2 | 967.9 Million INR | 9.34% |
| 2020 Q3 | 855.9 Million INR | -11.57% |
| 2020 FY | 3.42 Billion INR | 4.17% |
| 2020 Q4 | 719.44 Million INR | -15.94% |
| 2020 Q1 | 885.2 Million INR | -23.31% |
| 2019 Q3 | 680.3 Million INR | -37.52% |
| 2019 Q2 | 1.08 Billion INR | 196.03% |
| 2019 Q4 | 1.15 Billion INR | 69.67% |
| 2019 FY | 3.29 Billion INR | 54.44% |
| 2019 Q1 | 367.8 Million INR | -3.73% |
| 2018 Q3 | 530 Million INR | -40.02% |
| 2018 Q2 | 883.7 Million INR | 163.63% |
| 2018 Q1 | 335.2 Million INR | 1.24% |
| 2018 FY | 2.13 Billion INR | 30.76% |
| 2018 Q4 | 382.03 Million INR | -27.92% |
| 2017 FY | 1.62 Billion INR | 12.1% |
| 2017 Q4 | 331.1 Million INR | 0.0% |
| 2016 Q4 | 302.4 Million INR | 0.0% |
| 2016 FY | 1.45 Billion INR | -37.94% |
| 2015 Q3 | -39.3 Million INR | -114.3% |
| 2015 Q2 | 274.8 Million INR | 977.65% |
| 2015 Q1 | 25.5 Million INR | -40.12% |
| 2015 FY | 2.34 Billion INR | 870.17% |
| 2015 Q4 | 248 Million INR | 731.04% |
| 2014 FY | 241.48 Million INR | -18.21% |
| 2014 Q2 | 192.5 Million INR | 507.26% |
| 2014 Q3 | -25 Million INR | -112.99% |
| 2014 Q4 | 42.58 Million INR | 270.35% |
| 2014 Q1 | 31.7 Million INR | 150.2% |
| 2013 Q1 | 60.5 Million INR | 52.65% |
| 2013 Q4 | 12.67 Million INR | -56.31% |
| 2013 Q3 | 29 Million INR | -84.98% |
| 2013 Q2 | 193.1 Million INR | 219.17% |
| 2013 FY | 295.27 Million INR | 156.9% |
| 2012 Q3 | 102.5 Million INR | 733.33% |
| 2012 Q4 | 39.63 Million INR | -61.33% |
| 2012 FY | 114.93 Million INR | -91.17% |
| 2012 Q1 | -39.3 Million INR | -102.82% |
| 2012 Q2 | 12.3 Million INR | 131.3% |
| 2011 Q3 | -44.4 Million INR | 0.0% |
| 2011 FY | 1.3 Billion INR | 1108.63% |
| 2011 Q4 | 1.39 Billion INR | 3235.87% |
| 2010 FY | -129.01 Million INR | -132.63% |
| 2009 FY | 395.37 Million INR | 265.41% |
| 2008 Q4 | -14.7 Million INR | 0.0% |
| 2008 FY | 108.2 Million INR | -90.36% |
| 2007 FY | 1.12 Billion INR | 58.73% |
| 2006 FY | 706.81 Million INR | -9.98% |
| 2005 FY | 785.21 Million INR | 51.54% |
| 2004 FY | 518.16 Million INR | 65.77% |
| 2003 FY | 312.58 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | 56.38% |
| Hester Biosciences Limited | 188.89 Million INR | -1322.093% |
| Aarti Drugs Limited | 1.71 Billion INR | -56.704% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | -23.844% |
| Albert David Limited | 754.2 Million INR | -256.164% |
| Alkem Laboratories Limited | 17.95 Billion INR | 85.042% |
| Bafna Pharmaceuticals Limited | 73.47 Million INR | -3555.726% |
| Bajaj HealthCare Limited | -837.93 Million INR | 420.574% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -37776.354% |
| Brooks Laboratories Limited | -195.91 Million INR | 1471.072% |
| Eris Lifesciences Limited | 3.91 Billion INR | 31.472% |
| FDC Limited | 3.05 Billion INR | 11.993% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | 42.955% |
| Gufic Biosciences Limited | 861.35 Million INR | -211.856% |
| Hikal Limited | 696 Million INR | -285.947% |
| Ind-Swift Limited | 142.31 Million INR | -1787.523% |
| Innova Captab Limited | 943.45 Million INR | -184.72% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | -99.821% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | -1095.829% |
| Jubilant Pharmova Limited | 771 Million INR | -248.404% |
| Lincoln Pharmaceuticals Limited | 933.04 Million INR | -187.894% |
| Lupin Limited | 19.14 Billion INR | 85.969% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 3061.067% |
| Medico Remedies Limited | 82.9 Million INR | -3139.927% |
| Morepen Laboratories Limited | 961.59 Million INR | -179.346% |
| Nectar Lifesciences Limited | 49.95 Million INR | -5277.76% |
| Orchid Pharma Limited | 921.66 Million INR | -191.45% |
| Procter & Gamble Health Limited | 2 Billion INR | -33.655% |
| RPG Life Sciences Limited | 876.6 Million INR | -206.433% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | -1739.68% |
| Sigachi Industries Limited | 571.8 Million INR | -369.776% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 147.343% |
| Suven Pharmaceuticals Limited | 3 Billion INR | 10.544% |
| Themis Medicare Limited | 435.23 Million INR | -517.177% |
| Unichem Laboratories Limited | -704.74 Million INR | 481.159% |
| Vaishali Pharma Limited | 7.18 Million INR | -37265.294% |
| Wanbury Limited | 559.56 Million INR | -380.052% |
| Windlas Biotech Limited | 581.87 Million INR | -361.648% |
| ZIM Laboratories Limited | 172.46 Million INR | -1457.537% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | 36.189% |
| Ipca Laboratories Limited | 5.47 Billion INR | 50.924% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 97.195% |
| Venus Remedies Limited | 284.9 Million INR | -842.828% |
| Sakar Healthcare Limited | 116.7 Million INR | -2201.614% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 91.534% |
| Divi's Laboratories Limited | 16 Billion INR | 83.211% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | -66.317% |
| Mankind Pharma Limited | 19.12 Billion INR | 85.957% |
| Sequent Scientific Limited | -358.69 Million INR | 848.889% |
| Laurus Labs Limited | 1.6 Billion INR | -67.312% |
| Neuland Laboratories Limited | 3 Billion INR | 10.484% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 51.392% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 117.888% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 93.04% |
| Amrutanjan Health Care Limited | 449.72 Million INR | -497.295% |
| Wockhardt Limited | -4.63 Billion INR | 158.017% |
| Bal Pharma Limited | 73.92 Million INR | -3533.818% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 95.176% |
| Bliss GVS Pharma Limited | 754.54 Million INR | -256.003% |
| Par Drugs and Chemicals Limited | 145.01 Million INR | -1752.418% |
| Caplin Point Laboratories Limited | 4.57 Billion INR | 41.233% |
| Shilpa Medicare Limited | 318.74 Million INR | -742.748% |
| Valiant Laboratories Limited | 3.19 Million INR | -83948.529% |
| Ajanta Pharma Limited | 8.16 Billion INR | 67.088% |
| Aarey Drugs & Pharmaceuticals Limited | 46.83 Million INR | -5635.23% |
| Granules India Limited | 4.05 Billion INR | 33.725% |
| Medicamen Biotech Limited | 109.31 Million INR | -2357.406% |
| Syncom Formulations (India) Limited | 253.14 Million INR | -961.14% |
| Piramal Enterprises Limited | -16.83 Billion INR | 115.956% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | 83.783% |
| NATCO Pharma Limited | 13.88 Billion INR | 80.651% |
| Suven Life Sciences Limited | -1.05 Billion INR | 355.642% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 1461.586% |
| Strides Pharma Science Limited | -706.14 Million INR | 480.405% |
| Indoco Remedies Limited | 984.6 Million INR | -172.82% |
| Alpa Laboratories Limited | 167.76 Million INR | -1501.163% |
| Lasa Supergenerics Limited | -217.3 Million INR | 1336.133% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 169.372% |